MapLight Therapeutics logo
MapLight Therapeutics
MPLT | NASDAQ
Chart Builder DCF Calculator
$6.90
-$0.35 (-4.83%)
At close: Nov 16, 2026, 4:00 PM ET
$7.03
+$0.13 (+1.88%)
After-hours: Nov 16, 2026, 4:40 PM ET

MapLight Therapeutics Income Statement

Income statement explained
Fiscal Quarter
Period Ending
Q2 2026
Jun 30, 2026
Q1 2026
Mar 31, 2026
Q4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Q2 2025
Jun 30, 2025
Q1 2025
Mar 31, 2025
Q4 2024
Dec 31, 2024
Q3 2024
Sep 30, 2024
Q2 2024
Jun 30, 2024
Q1 2024
Mar 31, 2024
Q1 2023
Mar 31, 2023
– – – – – – – – – – –
147K 162K 140K 136K 136K 166K – – 173K 147K 128K
-147K -162K -140K -136K -136K -166K – – -173K -147K -128K
-63.55M -64.5M -83.38M -31.5M -30.66M -23.54M -22.78M -20.89M -19.99M -19.29M -12.17M
2.35M 2.47M 2.47M 1.55M 688K 811K 899K 1.08M 1.63M 890K 184K
-60.19M -60.67M -79.55M -29.42M -29.85M -22.34M -21.23M -19.02M -18.4M -18.94M -11.98M
-60.19M -60.67M -79.55M -29.42M -29.85M -22.34M -21.23M -19.02M -18.4M -18.94M -11.98M
9.97M 10.66M 18.75M 4.4M 3.82M 3.76M 2.06M 4.08M 4.34M 3.94M 1.62M
53.44M 53.68M 64.48M 27.09M 26.71M 19.62M 20.71M 16.81M 15.47M 15.2M 10.42M
– – – – – – – – – – –
63.4M 64.34M 83.24M 31.5M 30.53M 23.38M 22.78M 20.89M 19.81M 19.14M 12.04M
– – – – – – – – – – –
– – – – – – – – – – –
63.55M 64.5M 83.38M 31.5M 30.66M 23.54M 22.78M 20.89M 19.99M 19.29M 12.17M
– – – – – – – – – – –
45.43M 45.28M 44.02M 41.43M 41.43M 41.43M 41.43M 41.43M 41.43M 41.43M 41.43M
45.43M 45.28M 44.02M 41.43M 41.43M 41.43M 41.43M 41.43M 41.43M 41.43M 41.43M
-1.32 -1.34 -1.81 -0.71 -0.72 -0.54 -0.51 -0.46 -0.44 -0.46 -0.29
-1.32 -1.34 -1.81 -0.71 -0.72 -0.54 -0.51 -0.46 -0.44 -0.46 -0.29
-63.4M -60.51M -79.41M -29.28M -29.71M -22.17M -21.04M -18.83M -18.23M -18.79M -11.85M
-63.55M -60.67M -79.55M -29.42M -29.85M -22.34M -21.23M -19.02M -18.4M -18.94M -11.98M
147K 162K 140K 136K 136K 166K 194K 187K 173K 147K 128K

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.